← Blog
Browser & Computer Use comparison

Best Open-Source Browser & Computer Use: Stagehand vs Skyvern

A data-backed comparison of the top two browser & computer use on HVTracker, built from public trust signals rather than stars alone.

May 30, 2026 · 4 min read · Data updated 2026-05-30 20:03 UTC

Short answer: Stagehand currently leads Skyvern on HVTracker's evidence-weighted trust score: 86.1 vs 72.9/100. This is not a popularity ranking; it combines supply-chain safety, identity/provenance, transparency, maintenance, and adoption signals.

Stagehand

86.1
#15 overall · #1 in Browser & Computer Use · Grade B

The SDK For Browser Agents

Repositorybrowserbase/stagehand
Stars22.9k
Last push2026-05-29
Weekly commits55
Weekly downloads908,011

Skyvern

72.9
#31 overall · #2 in Browser & Computer Use · Grade B

Automate browser based workflows with AI

RepositorySkyvern-AI/skyvern
Stars21.8k
Last push2026-05-30
Weekly commits388
Weekly downloads2,015

Stagehand vs Skyvern: trust signal breakdown

Both projects are tracked in the Browser & Computer Use category, but they do not expose the same evidence. The table below compares the public signals that feed HVTrust.

SignalStagehandSkyvern
HVTrust score86.172.9
Safety / Integrity22.8/3016.5/30
Identity / Provenance20.0/2012.0/20
Transparency15.2/2017.0/20
Maintenance18.9/2020.0/20
Adoption9.2/107.4/10
OSSF Scorecard5.27.0
Signed commits100%100%
Package provenanceVerifiedNot detected

Which one should you evaluate first?

If your priority is the most verifiable trust profile today, start with Stagehand. It has the stronger current HVTrust score and ranks higher in Browser & Computer Use. If your use case depends on a specific runtime, language, license, or integration model, use the individual profiles rather than the headline score alone.

For production use, the practical checklist is: inspect the security policy, confirm package provenance or release signing where available, review recent maintenance cadence, and compare the exact trust breakdown. HVTracker is meant to reduce the first-pass research burden, not replace your own risk review.